Webcast

NOTE: Webcast must be viewed in its entirety in order to receive full credit

Release Date: 02/01/2016
Expiration Date: 02/01/2017

Estimated Time to Complete Activity: 1.5 hours

Clinical Updates in the Management of HCV

David Bernstein, MD

Hofstra North Shore-LIJ School of Medicine
Roslyn, NY

Target Audience - The educational initiative is intended for physicians, allied professionals, residents, fellows, and students from the specialties that we anticipate will be screening for, referring, and treating HCV and liver disease.

Statement of Need - The purpose of the activity to provide strategies to prevent disease, educate health care providers about the disease, increase disease surveillance, and improve the therapeutic management and patient outcomes.

Learning Objectives

Demonstrate proper patient selection for HCV screening based on careful consideration of risk and benefit and published guidelines

Assess advances in HCV treatment with emphasis on safety and efficacy for better patient outcomes

Accreditation Statement - This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Icahn School of Medicine at Mount Sinai and the Empire Liver Foundation (ELF). The Icahn School of Medicine at Mount Sinai is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement -The Icahn School of Medicine at Mount Sinai designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Faculty Disclosure Statement
It is the policy of Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. The information will be available as part of the course material.

Disclosure of Conflicts of Interest
Dr. David Bernstein is a Consultant/Advisor for AbbVie, Bristol-Myers Squibb, Gilead, Janssen and Merck. Dr. Bernstein has received consulting fees from AbbVie, Bristol-Myers Squibb and Gilead. Dr. Bernstein has received compensation for service on an advisory board from AbbVie, Bristol-Myers Squibb, Gilead, Janssen and Merck.

Course Director: Douglas Dieterich, MD
Professor of Medicine and Liver Disease
Icahn School of Medicine at Mount Sinai
New York, NY

Peer Reviewed by: Linda Law, MD
Assistant Professor Medicine, Liver Diseases
Icahn School of Medicine at Mount Sinai
No financial relationships to disclose.

Medium There are no fees for participating in or receiving credit for this online activity.

Method of Participation To receive a maximum of 1.25 AMA PRA Category 1 Credits ™
you should:

Review the activity objectives and CME information

View the presentations in this enduring material

All webcasts must be viewed in their entirety in order to receive full credit

Complete the posttest and activity evaluation form

A score of at least 70% is required to successfully complete this activity and receive CME credit

Hardware/software requirements Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox, and Google Chrome.

Privacy and Confidentiality Policy The Icahn School of Medicine protects the privacy of personal and other information regarding participants and educational collaborations. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

Disclaimer – The information provided in this webcast is for continuing education purposes only. The content is not meant to provide medical judgment, diagnostic or treatment options for any medical condition. Use of this information is not suitable outside the scope of this activity.

Contact Information: For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity at cme@mssm.edu. For technical assistance, contact info@focusmeded.com.

Copyright - This material is protected by copyright and other intellectual property laws. It may not be otherwise copied, printed, transmitted, or published unless explicit permission is obtained. To request permission, please contact us at info@focusmeded.com.

Commercial Support - This activity is supported from independent educational grants from AbbVie, Bristol-Myers Squibb, Gilead, Janssen Therapeutics and Merck.

 

Jointly provided by